Immune Design
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Immune Design and buy or sell other stocks, ETFs, and their options commission-free!About IMDZ
Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS.
CEORita A. Karachun
CEORita A. Karachun
Employees—
Employees—
HeadquartersKenilworth, New Jersey
HeadquartersKenilworth, New Jersey
Founded2008
Founded2008
Employees—
Employees—
IMDZ Key Statistics
Market cap282.03M
Market cap282.03M
Price-Earnings ratio-5.14
Price-Earnings ratio-5.14
Dividend yield—
Dividend yield—
Average volume178.76K
Average volume178.76K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.85
52 Week high$5.85
52 Week low$1.10
52 Week low$1.10
Stock Snapshot
With a market cap of 282.03M, Immune Design(IMDZ) trades at $5.85. The stock has a price-to-earnings ratio of -5.14.
Immune Design(IMDZ) stock opened on 2025-12-14 at —. The price climbed to — and dipped to —.
Immune Design(IMDZ) shares are trading with a volume of 0, against a daily average of 178.76K.
During the past year, Immune Design(IMDZ) stock moved between $1.10 at its lowest and $5.85 at its peak.
During the past year, Immune Design(IMDZ) stock moved between $1.10 at its lowest and $5.85 at its peak.